Key Takeaways FDA approval of Ciliatech’s IDE allows the company to begin a US feasibility study of the Intercil Uveal Spacer in approxima ...
Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements.
A Bayesian meta-analysis of 54 studies and more than 6.8 million cataract surgeries found antibiotic injection was associated with an approximately 79% reduction in the odds of postoperative ...
Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry ...
Key Takeaways Orbis' first Flying Eye Hospital simulation project in Macau will train 70 ophthalmologists and nurses from ...
Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry ...
Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry ...
SightGlass Vision says 2 million children worldwide have now worn Dot spectacle lenses, doubling the reported number of wearers in less than a year In the Cathay study, Dot lenses reduced mean myopia ...
TECLens closed a $10 million Series A2 extension financing, with participation from existing investors The funding will support expansion of the company's first-in-human qCXL clinical program, ...
Eye PCR has received the CE Mark under the European Union Medical Device Regulation (EU MDR 2017/745) for its fixOflex endocapsular device, enabling commercialization in Europe and other ...
The FDA has approved Lumvoa (veligrotug-vvze) for thyroid eye disease (TED), giving Viridian Therapeutics its first commercial product Approval was based on the phase 3 THRIVE and THRIVE-2 trials, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results